Development of national and multiagency HIV care quality measures

Clinical Infectious Diseases

Volumn 51, Issue 6, 2010, Pages 732-738

  Horberg, Michael A ^a   Aberg, Judith A ^d   Cheever, Laura W ^e   Renner, Philip ^f   Kaleba, Erin O'brien ^g   Asch, Steven M ^b,c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^f NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^g Alliance of Chicago Community Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; SEXUAL BEHAVIOR;

HEALTH POLICY; HEALTH SERVICES ADMINISTRATION; HIV INFECTIONS; HUMANS; QUALITY ASSURANCE, HEALTH CARE;

EID: 77955948522     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655893     Document Type: Article

References (50)

1. Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002; 31(Suppl 3):S112-7.
2. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med 2003; 11:185-198
3. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the InfectiousDiseases Society of America. Clin Infect Dis 2009; 49:651-681
4. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIVinfected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4):1-207.
5. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care 2002; 14(Suppl 1):S109-18.
6. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 2):S171-6.
7. Messeri PA, Abramson DM, Aidala AA, Lee F, Lee G. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care 2002; 14(Suppl 1):S15-29.
8. Office of Medical Director, New York State Department of Health AIDS Institute. New York State HIV quality of care program. 2009. http://www.hivguidelines.org/quality-of-care/nys-hiv-quality-of-care-program/. Accessed 21 December 2009
9. Horberg M. HIV quality measures in Kaiser Permanente [panel 1C]. In: Program and abstracts of the NCQA 4th Annual National Policy Conference (Washington, DC). 2009.
10. Bozzette SA, Phillips B, Asch S, et al. Quality enhancement research initiative for human immunodeficiency virus/acquired immunodeficiency syndrome: framework and plan. HIV-QUERI Executive Committee. Medical Care 2000; 38(Suppl 1):I60-9.
11. Health Resources and Services Administration. HIVQUAL continuous quality program. US Department of Health and Human Services, 2009. http://hab.hrsa.gov/ special/hivqual.htm. Accessed 21 December 2009.
12. Health Resources and Services Administration. The HIV/AIDS Program: HAB performance measures. US Department of Health and Human Services, 2009. http://hab.hrsa.gov/special/habmeasures.htm.Accessed 21 December 2009.
13. HIVQUAL-US: mission and history. 2010. http://www.hivqual.org/index.cfm/ 8018. Accessed 23 February 2010.
14. Institute of Medicine of the National Academies. Measuring whatmatters: allocation, planning, and quality assessment for the Ryan White CARE Act. Washington, DC: Institute of Medicine, 2004.
15. McGlynn EA, Asch SM. Developing a clinical performance measure. Am J Prev Med 1998; 14(3 Suppl):14-21.
16. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system of the 21st century. Washington, DC: Institute of Medicine, 2001.
17. Bartlett JG, Cheever LW, Johnson MP, Paauw DS, eds. A guide to primary care of people with HIV/AIDS. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, 2004:1-167.
18. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Department of Health and Human Services, 2009:1-139.
19. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004; 39:609-629
20. Centers for Disease Control and Prevention; Health Resources and Services Administration; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003; 52(RR-12):1-24.
21. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42.
22. St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002; 92:1784-1788
23. Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis 2000; 27:53-59
24. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18:2075-2079
25. Horberg MA, Ranatunga DK, Quesenberry CP, Klein DB, Silverberg MJ. Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis 2010; 37:53-58
26. Korthuis PT, Anaya HD, Bozzette SA, et al. Quality of HIV care within the Veterans Affairs health system: a comparison using outcomes from the HIV Cost and Services Utilization Study. J Clin Outcomes Manag 2004; 11:765-774
27. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55(RR-11):1-94 (erratum: MMWR Recomm Rep 2006; 55:997).
28. Office of the Medical Director, New York State Department of Health AIDS Institute. How to Integrate Prevention into Primary Care. New York State Department of Health AIDS Institute, 2005:1-11.
29. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340:367-373
30. Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137:435-478
31. Toossi Z, Mayanja-Kizza H, Hirsch CS, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001; 123:233-238
32. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151:129-135
33. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol 1997; 27:18-24.
34. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56(RR-6):1-54.
35. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441-446
36. Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281:901-907
37. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-1340
38. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53(RR-15):1-112.
39. Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001; 32:794-800.
40. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117:314-324
41. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-15):1-48.
42. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committeeon Immunization Practices (ACIP), part II: immunization of adults. MMWR Recomm Rep 2006; 55(RR-16):1-33.
43. Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virusinfected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J Infect Dis 1998; 178:1126-1132
44. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990; 322:161-165
45. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2009:1-161.
46. Centers for Medicare and Medicaid Services. 2010 PQRI measures list. 2010.
47. HAB HIV core clinical performance measures for adult/adolescent clients: group 1. Department of Health and Human Services, Health Resources and Services Administration, 2008:1-10.
48. HAB HIV core clinical performance measures for adult/adolescent clients: group 2. Department of Health and Human Services, Health Resources and Services Administration, 2008:1-21.
49. HAB HIV core clinical performance measures for adult/adolescent clients: group 3. Department of Health and Human Services, Health Resources and Services Administration, 2008:1-22.
50. Gibson TB, Lee TA, Vogeli CS, et al. A four-system comparison of patients with chronic illness: the Military Health System, Veterans Health Administration, Medicaid, and commercial plans. MilitaryMed 2009; 174:936-943